Skip to main content
. Author manuscript; available in PMC: 2016 Mar 14.
Published in final edited form as: Lancet. 2014 Nov 26;385(9972):977–1010. doi: 10.1016/S0140-6736(14)62038-9

Table 2.

Data quality indicators for patients diagnosed during 1995–2009, by continent and country (all cancers combined)

Calendar
period
Patients
submitted
(n)
Ineligible patients
Eligible
patients (n)
Exclusions
Available for
analysis (n)
Data quality indicators††
In situ
(%)
Other
(%)
DCO (%) Other (%) MV (%) Non-specific
morphology
(%)
Lost to
follow-
up (%)
Censored
(%)
Africa 23 325 0·2% 39·5% 14 048 1·4% 9·6% 12 509 85·5% 17·0% 10·2% 28·8%
    Algerian registries 1995–2009 6919 <0·1% 5·8% 6515 0·3% 17·4% 5358 93·8% 12·3% 0·0% 21·5%
    Lesotho (childhood) 1995–2009 22 0·0% 0·0% 22 0·0% 0·0% 22 100·0% 0·0% 0·0% 11·8%
    Libya (Benghazi) 2003–2005 1698 0·0% 0·4% 1692 8·9% 0·5% 1533 84·4% 16·5% 0·0% 32·4%
    Mali (Bamako) 1995–2009 1007 0·0% 78·3% 219 5·0% 2·3% 203 58·6% 41·4% 83·7% 6·4%
    Mauritius* 2005–2005 855 0·0% 0·6% 850 0·0% 0·9% 842 100·0% 24·1% 0·0% NA
    Nigeria (Ibadan) 1998–2007 2192 2·1% 60·1% 830 0·6% 3·6% 795 70·8% 0·0% 8·9% 65·1%
    South Africa (Eastern Cape) 1998–2007 2404 0·0% 2·9% 2335 0·1% 4·4% 2230 70·5% 32·8% 45·7% 25·1%
    The Gambia* 1995–1997 387 0·0% 10·1% 348 0·9% 10·3% 309 15·2% 58·9% 3·2% 14·2%
    Tunisia (Central) 1995–2007 7841 0·1% 84·1% 1237 NA 1·6% 1217 99·1% 1·0% 0·7% 51·2%
America (Central and South) 467 456 3·0% 8·0% 416 140 13·7% 0·7% 356 173 87·4% 7·7% 0·1% 2·9%
    Argentinian registries 1995–2009 40 482 5·0% 7·6% 35 377 11·1% 0·5% 31 244 97·9% 3·7% <0·1% 14·6%
    Brazilian registries 1995–2009 119 423 5·4% 20·0% 89 067 9·5% 0·5% 80 113 92·8% 7·1% 0·2% 1·7%
    Chilean registries 1998–2008 8920 8·2% 0·7% 8121 10·7% 0·5% 7213 90·3% 4·1% 0·5% 0·0%
    Colombian registries 1995–2009 36 140 1·5% 5·7% 33 550 5·7% 0·8% 31 365 88·5% 12·0% <0·1% 19·5%
    Cuba* 1998–2006 120 748 0·3% 2·1% 117 883 23·7% 0·3% 89 576 70·6% 11·7% 0·0% 0·0%
    Ecuadorian registries 1995–2009 35 395 1·3% 5·7% 32 924 9·7% 4·3% 28 314 92·0% 3·7% 0·0% <0·1%
    Puerto Rico* 2000–2009 81 886 3·9% 4·5% 74 937 6·7% 0·3% 69 745 97·2% 1·4% 0·0% 0·0%
    Uruguay* 2002–2009 24 462 0·4% 0·3% 24 281 23·4% 0·0% 18 603 80·6% 20·9% 0·0% 0·0%
America (North) 12 233 257 6·0% 1·3% 11 340 569 1·8% 0·2% 11 109 332 94·8% 1·3% 0·8% <0·1%
    Canada* 1995–2009 1 392 677 4·3% 0·6% 1 324 227 1·8% 0·5% 1 294 159 88·7% 1·5% 0·0% <0·1%
    US registries 1995–2009 10 840 580 6·2% 1·4% 10 016 342 1·8% 0·2% 9 815 173 95·6% 1·3% 0·9% <0·1%
Asia 3 581 339 3·3% 0·9% 3 432 472 4·4% 0·2% 3 274 733 83·1% 11·4% 0·7% 2·6%
    Chinese registries 1995–2009 241 044 0·1% 1·3% 237 656 1·6% <0·1% 233 736 66·4% 38·7% 3·5% 0·1%
    Cyprus* 2004–2009 9986 2·8% 2·7% 9437 8·6% 0·2% 8609 98·7% 2·1% 0·0% 0·1%
    Hong Kong* 1997–2006 6184 0·0% 0·0% 6184 0·0% 0·2% 6169 99·6% <0·1% 9·0% 8·5%
    Indian registries 1995–2009 11 732 0·0% 1·5% 11 551 2·7% 0·1% 11 235 81·8% 9·7% 22·9% 9·9%
    Indonesia (Jakarta) 2005–2007 3830 0·0% 18·1% 3138 1·3% 0·2% 3091 75·4% 23·0% 0·0% NA
    Israel* 1995–2009 202 745 6·1% 2·0% 186 266 3·2% 0·2% 179 921 94·2% 6·4% 0·0% 0·0%
    Japanese registries 1995–2009 1 065 707 3·7% 1·0% 1 015 315 13·3% <0·1% 879 341 86·4% 9·9% 0·0% 3·6%
    Jordan* 2000–2009 19 191 0·0% 0·6% 19 081 <0·1% 0·9% 18 896 99·3% 1·5% 54·9% 0·0%
    Korea* 1995–2009 1 191 749 0·0% 0·8% 1 182 442 <0·1% 0·1% 1 180 925 82·5% 8·9% 0·0% 0·0%
    Malaysia (Penang) 1995–2009 15 842 0·0% 2·5% 15 447 2·4% 1·8% 14 800 92·0% 9·8% 0·0% <0·1%
    Mongolia* 2005–2009 13 415 1·8% 0·6% 13 096 <0·1% 4·5% 12 510 35·7% 1·2% 16·9% NA
    Qatar* 2002–2009 780 0·8% 0·1% 773 2·7% 0·4% 749 90·0% 6·4% 0·0% 5·1%
    Saudi Arabia* 1995–2008 24 216 1·4% 0·1% 23 876 2·6% 10·1% 20 860 95·2% 1·6% 0·0% 61·3%
    Taiwan* 1995–2009 662 906 9·2% <0·1% 601 480 0·0% 0·1% 600 934 83·1% 9·6% 0·0% 0·0%
    Thai registries 1995–2009 47 263 1·4% 0·7% 46 279 4·0% 0·1% 44 406 58·5% 38·4% 0·1% 23·4%
    Turkey (Izmir) 1995–2009 64 749 3·3% 3·4% 60 451 3·0% 0·2% 58 551 92·9% 2·1% <0·1% 30·7%
Europe 11 449 869 6·5% 1·0% 10 584 050 4·5% 0·2% 10 086 145 89·7% 3·5% 0·3% 0·4%
    Austria* 1995–2009 353 194 6·9% 0·6% 326 730 0·1% 0·9% 323 432 97·6% 2·5% 0·0% 0·0%
    Belarus (childhood) 1995–2009 726 0·0% 0·0% 726 0·0% 0·0% 726 99·9% 0·0% 2·8% 0·0%
    Belgium* 2004–2009 256 073 8·7% 0·6% 232 152 <0·1% 0·2% 231 734 98·7% 1·5% 1·1% 0·0%
    Bulgaria* 1995–2009 255 768 <0·1% 0·2% 255 158 11·2% <0·1% 226 566 81·4% 1·3% 0·1% 0·0%
    Croatia* 1998–2009 148 131 0·0% 0·1% 148 031 6·0% <0·1% 139 147 84·9% 0·4% 0·0% 0·0%
    Czech Republic* 1995–2009 469 330 6·4% 1·3% 433 523 7·9% 0·9% 395 462 90·8% 1·9% 0·0% 0·0%
    Denmark* 1995–2009 251 533 0·0% 0·2% 250 931 0·4% 0·0% 249 943 93·2% 8·0% 0·1% 0·0%
    Estonia* 1995–2008 51 544 1·4% 1·1% 50 283 3·8% 0·4% 48 193 89·0% 3·5% 0·4% 0·0%
    Finland* 1995–2009 235 156 6·5% 2·9% 213 137 2·3% <0·1% 208 129 96·1% 7·3% 0·1% 0·0%
    French registries 1995–2009 227 210 <0·1% 0·3% 226 622 <0·1% 0·2% 226 234 96·3% 2·6% 3·9% 4·1%
    German registries 1995–2009 1 668 355 4·0% 1·2% 1 582 464 13·5% 0·1% 1 367 345 94·9% 1·0% 0·3% 0·1%
    Gibraltar* 1999–2009 665 13·8% 15·8% 468 NA 1·3% 462 85·7% 0·9% 0·0% 2·2%
    Iceland* 1995–2009 10 805 0·0% 0·8% 10 722 0·2% 0·0% 10 704 97·2% 2·8% 0·0% 0·0%
    Ireland* 1995–2009 169 818 14·9% 1·4% 142 134 2·4% 0·1% 138 602 91·0% 1·1% 0·0% 0·0%
    Italian registries 1995–2009 877 272 2·7% 0·5% 849 556 2·1% 0·2% 830 162 87·5% 12·5% 0·8% 1·0%
    Latvia* 1995–2009 78 334 0·1% 0·2% 78 141 6·1% 0·5% 72 992 81·5% 0·5% 0·0% 0·0%
    Lithuania* 1995–2009 132 425 2·8% 0·5% 127 999 3·6% 0·0% 123 380 84·9% 2·0% 1·0% 0·0%
    Malta* 1995–2009 11 630 0·0% 0·9% 11 526 2·6% 0·5% 11 173 96·3% 7·9% 0·0% <0·1%
    Netherlands* 1995–2009 716 617 2·9% 0·9% 688 714 0·3% 0·3% 684 601 97·0% 3·1% 0·5% 0·0%
    Norway* 1995–2009 202 823 0·0% 0·4% 202 016 0·8% 0·0% 200 334 95·5% 4·7% 0·2% 0·0%
    Poland* 1995–2009 813 485 1·2% 0·2% 802 179 4·1% 0·4% 766 183 79·6% 0·5% 0·1% 0·0%
    Portugal* 1998–2009 240 114 2·8% 2·7% 226 878 0·2% 0·2% 225 902 95·9% 3·3% 0·1% 1·4%
    Romania (Cluj) 2006–2009 6900 3·9% 0·7% 6583 18·0% 2·0% 5264 93·0% 0·8% 0·0% NA
    Russia (Arkhangelsk) 2000–2009 23 609 0·0% <0·1% 23 602 3·3% 0·7% 22 643 82·4% 3·5% 1·1% 0·0%
    Slovakia* 2000–2007 92 942 0·0% 0·3% 92 655 9·9% <0·1% 83 449 95·3% 5·5% 0·0% 0·0%
    Slovenia* 1995–2009 95 466 14·8% 2·5% 78 973 2·7% <0·1% 76 835 94·5% 5·9% 0·1% 0·0%
    Spanish registries 1995–2009 338 249 3·9% 2·4% 317 154 2·6% 0·3% 308 081 91·5% 5·4% 0·2% 0·8%
    Sweden* 1995–2009 395 792 0·0% <0·1% 395 744 NA 0·0% 395 744 98·9% 2·1% 0·2% 0·0%
    Swiss registries 1995–2009 151 879 6·9% 0·4% 140 737 1·7% 0·1% 138 125 95·2% 2·9% 3·2% 6·0%
    UK* 1995–2009 3 174 024 14·5% 1·4% 2 668 512 3·5% 0·1% 2 574 598 83·3% 3·4% <0·1% 0·1%
Oceania 930 199 7·5% 0·6% 855 312 1·8% 0·2% 837 995 92·0% 4·2% 0·0% 4·1%
    Australian registries 1995–2009 766 090 9·1% 0·7% 691 260 1·4% 0·2% 680 295 91·9% 3·4% 0·0% 5·0%
    New Zealand* 1995–2009 164 109 0·0% <0·1% 164 052 3·3% 0·6% 157 700 92·6% 7·6% 0·0% 0·0%
Total 28 685 445 5·9% 1·3% 26 642 591 3·4% 0·2% 25 676 887 91·1% 3·7% 0·6% 0·7%

NA=not available.

*

100% coverage of the national population.

100% coverage of the national population for childhood leukaemia only.

South Korea.

In situ malignant disease (ICD-O-3 behaviour code 2): some registries do not register in situ cancers, other registries did not submit them. Other: records with incomplete data; or tumours that are benign (behaviour code 0), of uncertain behaviour (1), metastatic from another organ (6), or unknown if primary or metastatic (9); or patients falling outside the age range 0–14 years (children) or 15–99 years (adults); or other conditions.

DCO=tumours registered from a death certificate only or detected solely at autopsy. Other: vital status or sex unknown; or invalid sequence of dates; or inconsistency of sex-site, site-morphology, age-site, age-morphology, or age-site-morphology.

††

MV=microscopically verified. Non-specific morphology (solid tumours only): ICD-O-3 morphology code in the range 8000–8005. Censored: patients diagnosed during 1995–2004, with last known vital status “alive” but less than 5 years of follow-up.